Friday, July 10, 2026

pharma · Colitis, Ulcerative · Multiple Myeloma

Janssen Cilag International

News and analysis for Janssen Cilag International on NovaPharmaNews — regulatory, clinical, and market coverage.

São Paulo, EU HQ
13 Employees
EMA registrant Type
Company details
Status
Public
HQ
São Paulo, EU
Employees
13
Programs
46
Drugs
37
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Janssen Cilag International — regulatory, clinical, and market coverage.

News and analysis for Janssen Cilag International on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Janssen Cilag International yet.

Back to company overview →